Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immune-Stromal Landscape of Muscle-Invasive Urothelial Bladder Carcinoma: A Morphological Histopathological Study

NCT07525349 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07525349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07525349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immune-Stromal Landscape of Muscle-Invasive Urothelial Bladder Carcinoma: A Morphological Histopathological Study
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, muscle-invasive bladder carcinoma, muscle-invasive urothelial bladder carcinoma, urinary bladder neoplasms, urothelial carcinoma (uc)